| Passive transcellular | Drug-like neutrals | Caffeine, Aspirin, Antipyrine | ~ −5.0 to −5.5 | Within 0.3 log unit |
| Paracellular tight-junction | Small flexible molecules | Atenolol-class | ~ −5.5 to −6.0 | Within 0.3 log unit |
| LAT1 large-amino-acid transporter | Tryptophan / phenylalanine mimetics | Tryptophanamide | −4.92 | −4.91 |
| SERT / OCT-like monoamine | Small monoamine + aromatic | Serotonin | −4.86 | −4.85 |
| 4-quinolone-3-carboxylate intramol chelate | Fluoroquinolone antibiotics | Sparfloxacin | −4.78 | −5.09 |
| PEPT1 peptide transporter | Beta-lactams (penicillins, cephalosporins) | Ceftriaxone | −6.60 | −6.66 |
| Macrocycle intramol H-bond foldability | Cyclic peptides (cyclosporin class) | Cyclic hexapeptide 09 | −5.30 | −5.32 |
| SGLT-like sugar transport | Glycoside drugs | Digoxin | −5.63 | −5.78 |
| Anthranilic / β-amino-acid salt bridge | Anthranilic acid analogs | Amfenac | −4.52 | −5.06 |
| P-gp efflux with foldability competition | Lipophilic basic amines | Chlorprothixene | −4.74 | −4.21 |
| MATE1 / OCT1 cation efflux | Compact lipophilic mono-cations | Astemizole | −5.15 | −4.90 |
| Rigid alkaloid cage shielding | Strychnine / morphinan class | Pseudostrychnine | −4.60 | −4.69 |
| Halogen lipophilic membrane bonding | Polyhalogenated lipophilics | 2h research compound | −4.60 | −5.21 |
| Acyloxymethyl P-gp-bypass prodrug | Chimeric ester linkers | EF5264 | −4.51 | −5.11 |